The influence of the inactivating agent on the antigen content of inactivated Newcastle disease vaccines assessed by the in vitro potency test

Biologicals

Volumn 38, Issue 1, 2010, Pages 128-134

  Jagt, H J M ^a   Bekkers, M L E ^a   van Bommel, S A J T ^a   van der Marel, P ^a   Schrier, C C ^a  

^a INTERVET INTERNATIONAL BV   (Netherlands)

Author keywords

ELISA; In vitro; Newcastle disease; Quality control; Vaccine

Indexed keywords

FORMALDEHYDE; INACTIVATED VIRUS VACCINE; NEWCASTLE DISEASE VACCINE; PROPIOLACTONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ANTIVIRAL ACTIVITY; ARTICLE; BIRD DISEASE; CONTROLLED STUDY; DRUG FORMULATION; DRUG POTENCY; DRUG QUALITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMAGGLUTINATION; IMMUNOGENICITY; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; QUALITY CONTROL; VACCINE PRODUCTION; VIRUS INACTIVATION;

ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CHICK EMBRYO; CHICKENS; DISINFECTANTS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FORMALDEHYDE; HEMAGGLUTINATION TESTS; NEUTRALIZATION TESTS; NEWCASTLE DISEASE; NEWCASTLE DISEASE VIRUS; POULTRY DISEASES; PROPIOLACTONE; QUALITY CONTROL; VACCINES, INACTIVATED; VIRAL VACCINES; VIRUS INACTIVATION;

ANIMALIA; NEWCASTLE DISEASE VIRUS;

EID: 77649337761     PISSN: 10451056     EISSN: 10958320     Source Type: Journal    
DOI: 10.1016/j.biologicals.2009.07.006     Document Type: Article

References (17)

1. European pharmacopoiea. 5th ed. Monograph 01/2007:0870 (2007), European Department for the Quality of Medicines Within the Council of Europe, Strassbourg, France
2. Maas R., de Winter M., Venema S., Oei H., and Claassen I. Antigen quantification as in vitro alternative for potency testing of inactivated viral poultry vaccines. Vet Q 22 (2000) 223-227
3. Maas R., Komen M., van Diepen M., Oei H., and Claassen I. Correlation of heamagglutinin-neuraminidase and fusion protein content with protective antibody response after immunisation with inactivated Newcastle disease vaccines. Vaccine 21 (2003) 3137-3142
4. Claassen I., Maas R., Daas A., and Milne C. Feasibility study to evaluate the correlation between results of a candidate in vitro assay and established in vivo assay for potency determination of Newcastle disease vaccines. PharmEuropa Bio 1 (2003)
5. Claassen I., Maas R., Oei H., Daas A., and Milne C. Validation study to evaluate the reproducibility of a candidate in vitro potency assay of Newcastle disease vaccines and to establish the suitability of a candidate biological reference preparation. PharmEuropa Bio 1 (2004)
6. Halder M. Three Rs potential in the development and quality control of immunobiologicals. Altex 18 Suppl. 1 (2001) 13-47
7. Maas R., de Winter M., Koch G., Oei H., and Bongers J. Development of an in vitro potency test for inactivated Newcastle disease vaccines. Progress in the reduction and replacement of animal experimentation. Dev in Animal and Veterinary Sci 31 (2000) 959-967
8. Spearman C., and Kaerber G. In: Bibrack B., and Whittmann G. (Eds). Virologische arbeitsmethoden (1974), Fisher Verlag, Stuttgart 37-39
9. King D.J. Evaluation of different methods of inactivation of Newcastle disease virus andavian influenza virus in egg fluids and serum. Avian Dis 35 (1990) 505-514
10. Finney D.J. Probit analysis. 3rd ed. (1971), Cambridge Univ Press
11. Doel T.R. Inactivation of viruses produced in animal cell cultures. In: Spier R.E., and Griffiths J.B. (Eds). Animal cell biotechnology vol. 2 (1985), Academic Press, New York 129-149
12. Hanson C.V. Inactivation of viruses for use as vaccines and immunodiagnostic reagents. In: de la Maza L.M., and Peterson E.M. (Eds). Medical virology II (1982), Elsevier Biomedical, New York 45-79
13. Brusick D.J. The genetic properties of beta-propiolactone. Mutat Res 39 3-4 (1976) 241-255
14. Perrin P., Morgeaux S., and Sureau P. In vitro rabies vaccine potency appraisal by ELISA: advantages of the immunocapture method with a neutralising anti-glycoprotein monoclonal antibody. Biologicals 18 (1990) 321-330
15. Freidlin P.J., Snyder D.B., Marquardt W.W., Savage P.K., Lana D.P., and Srinivasappa G.B. The effect of formalin treatment on haemagglutination inhibition epitopes of Newcastle disease virus recognized by monoclonal and polyclonal antibodies. Israel J Vet Med 44 (1988) 87-91
16. Beard C.W., Hopkins S.R., and Hammond J. Preparation of Newcastle disease virus haem-agglutination inhibition test antigen. Avian Dis 19 (1975) 692-699
17. Park B.K., Jeon Y.S., Lee Y.S., and Rhee Y.O. Studies on the antigenicity and immunogenicity of Newcastle disease virus inactivated with binary ethylenimine. Korean J Vet Res 25 (1985) 155-166